Literature DB >> 18342948

How do mutant Nav1.1 sodium channels cause epilepsy?

David S Ragsdale1.   

Abstract

Voltage-gated sodium channels comprise pore-forming alpha subunits and auxiliary beta subunits. Nine different alpha subtypes, designated Nav1.1-Nav1.9 have been identified in excitable cells. Nav1.1, 1.2 and 1.6 are major subtypes in the adult mammalian brain. More than 200 mutations in the Nav1.1 alpha subtype have been linked to inherited epilepsy syndromes, ranging in severity from the comparatively mild disorder Generalized Epilepsy with Febrile Seizures Plus to the epileptic encephalopathy Severe Myoclonic Epilepsy of Infancy. Studies using heterologous expression and functional analysis of recombinant Nav1.1 channels suggest that epilepsy mutations in Nav1.1 may cause either gain-of-function or loss-of-function effects that are consistent with either increased or decreased neuronal excitability. How these diverse effects lead to epilepsy is poorly understood. This review summarizes the data on sodium channel mutations and epilepsy and builds a case for the hypothesis that most Nav1.1 mutations have their ultimate epileptogenic effects by reducing Nav1.1-mediated whole cell sodium currents in GABAergic neurons, resulting in widespread loss of brain inhibition, an ideal background for the genesis of epileptic seizures.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18342948     DOI: 10.1016/j.brainresrev.2008.01.003

Source DB:  PubMed          Journal:  Brain Res Rev        ISSN: 0165-0173


  31 in total

Review 1.  SCN1A mutations in Dravet syndrome: impact of interneuron dysfunction on neural networks and cognitive outcome.

Authors:  Alex C Bender; Richard P Morse; Rod C Scott; Gregory L Holmes; Pierre-Pascal Lenck-Santini
Journal:  Epilepsy Behav       Date:  2012-02-16       Impact factor: 2.937

Review 2.  Genetic influences on ketogenic diet efficacy.

Authors:  Stacey B B Dutton; Andrew Escayg
Journal:  Epilepsia       Date:  2008-11       Impact factor: 5.864

3.  Voltage-gated Na+ channels: potential for beta subunits as therapeutic targets.

Authors:  William J Brackenbury; Lori L Isom
Journal:  Expert Opin Ther Targets       Date:  2008-09       Impact factor: 6.902

Review 4.  Sodium channel blockers for the treatment of neuropathic pain.

Authors:  Anindya Bhattacharya; Alan D Wickenden; Sandra R Chaplan
Journal:  Neurotherapeutics       Date:  2009-10       Impact factor: 7.620

Review 5.  Subtype-selective targeting of voltage-gated sodium channels.

Authors:  Steve England; Marcel J de Groot
Journal:  Br J Pharmacol       Date:  2009-10-20       Impact factor: 8.739

6.  A persistent little current with a big impact on epileptic firing.

Authors:  Carl E Stafstrom
Journal:  Epilepsy Curr       Date:  2011-03       Impact factor: 7.500

7.  Nav1.1 modulation by a novel triazole compound attenuates epileptic seizures in rodents.

Authors:  John Gilchrist; Stacey Dutton; Marcelo Diaz-Bustamante; Annie McPherson; Nicolas Olivares; Jeet Kalia; Andrew Escayg; Frank Bosmans
Journal:  ACS Chem Biol       Date:  2014-03-31       Impact factor: 5.100

Review 8.  Physiological bases of the K+ and the glutamate/GABA hypotheses of epilepsy.

Authors:  Mauro DiNuzzo; Silvia Mangia; Bruno Maraviglia; Federico Giove
Journal:  Epilepsy Res       Date:  2014-04-21       Impact factor: 3.045

Review 9.  Electrogenic tuning of the axon initial segment.

Authors:  Brian D Clark; Ethan M Goldberg; Bernardo Rudy
Journal:  Neuroscientist       Date:  2009-12       Impact factor: 7.519

10.  Functional modulation of voltage-dependent sodium channel expression by wild type and mutated C121W-β1 subunit.

Authors:  Debora Baroni; Raffaella Barbieri; Cristiana Picco; Oscar Moran
Journal:  J Bioenerg Biomembr       Date:  2013-04-13       Impact factor: 2.945

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.